Recombinant protein technology provider Healthgen netted over $87m while shared living space provider Hmlet is buying corporate-backed peer Habyt and Uniswap Labs is launching an investment vehicle.

Funding Pharmaceutical company Betta Pharmaceuticals has co-led a RMB556m ($87.3m) funding round for China-based recombinant protein technology developer Healthgen Biotechnology, DealStreetAsia reported yesterday, citing a company announcement. The investor that co-led the round was not disclosed but it is expected to be the last for Healthgen before it launches an initial public offering. Tive, a US-based provider of supply chain visibility software, completed a $54m series B round yesterday led by Axa Venture Partners, the venture capital firm sponsored by insurance firm Axa. The round included Qualcomm Ventures, the investment arm of mobile chipmaker Qualcomm, as well as Sorenson Capital, Fifth Wall, SJF Ventures, Floating Point Ventures, RRE Ventures, Two Sigma Ventures, NextView Ventures, Hyperplane Ventures, Broom Ventures and Supply Chain Ventures. China-headquartered game development software provider Cocos Technology closed a $50m series B round yesterday backed by interactive streaming platform developer Agora. The round also featured financial services firm China Construction Bank’s CCB Trust subsidiary and VC firm GGV Capital. China-based autonomous driving technology developer Haomo.AI raised hundreds of millions of yuan (RMB100m = $15.7m) in series A-plus financing yesterday from investors including conglomerate Shoucheng Holdings. Financial services firm Bank of China led the round through subsidiary Bank of China Group Investment and it came four months after Shoucheng contributed to a $157m series A round also backed by local services portal Meituan and Qualcomm Ventures, a subsidiary of mobile semiconductor producer Qualcomm. US-headquartered robotic automation technology developer Diligent Robotics secured over $30m yesterday in a series B round featuring healthcare provider Cedars-Sinai’s strategic investment arm, Cedars-Sinai Health Ventures. The round was led by Tiger Global Management and included Massachusetts Institute of Technology Media Lab’s E14 Fund, True Ventures, DNX Ventures, Ubiquity Ventures, Next Coast Ventures, Boom Capital and Gaingels. PhableCare, the India-based developer of a chronic disease management app, received Rs 1.87bn ($24.6m) in series B funding yesterday from investors including Aflac Ventures and Omron Ventures, which participated on behalf insurer Aflac and medical device maker Omron. VC firm Kalaari Capital led the round, which also featured Digital Horizon, Stride Ventures, SOSV, Social Starts and Fresco Capital. Deutsche Bank Corporate Venture Capital, a subsidiary of financial services firm Deutsche Bank, provided a ‘sizeable’ amount of equity funding yesterday for SkyHive, a US-headquartered producer of human capital management software. It came six months after SkyHive raised $40m in series B funding from investors including Accenture Ventures and Workday Ventures – on behalf of consulting firm Accenture and enterprise software…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Robert Lavine

Robert Lavine is special features editor for Global Venturing.